WITHIN THE LAST SEVERAL YEARS, vasodilator drugs have been found capable of increasing cardiac output while lowering cardiac filling pressure in cardiogenic shock and in left ventricular failure in man. Presumably the reduced left ventricular afterload permits the damaged ventricle to maintain or improve stroke volume at the same or lower ventricular filling pressure, thus reducing myocardial oxygen consumption. Some of these drugs may lower cardiac filling pressure also by a dilating action upon the venous capacitance bed. Among the drugs used for this purpose are:
nitroglycerin,"' isosorbide dinitrate,3-' phentolamine, 6 8 nitroprusside,9"-1 hydralazine,'6 and phenoxybenzamine. 17 These agents have been found useful in acute cardiac infarction with cardiogenic shock, chronic heart failure with ischemic heart disease, refractory heart failure of other cause, and in congestive cardiomyopathy. Hemodynamic benefits have also been found in aortic insufficiency'8 and in severe mitral insufficiency. '9 Cardiac tamponade is a hemodynamic disorder associated with a fall in cardiac stroke volume, decreased cardiac output, a lesser fall in blood pressure, and consequently an increase of systemic vascular resistance.20 Thus, a drug which tends to lower systemic vascular resistance might increase cardiac stroke volume by improving left ventricular ejection fraction in the face of an unchanged filling pressure of the cardiac ventricles.
Accordingly, we decided to test the hemodynamic effects of sodium nitroprusside and of hydralazine in dogs with experimental cardiac tamponade. Nitroprusside tends to reduce the cardiac filling pressure by dilating the venous capacitance bed; thus we studied the effects of nitroprusside in two groups of animals with tamponade. In the first group, nitroprusside infusion was permitted to decrease cardiac filling pressure as well as systemic vascular resistance. In the second group, cardiac filling pressure was maintained at the original tamponade level by autologous blood transfusion. In a third group, we investigated the hemodynamic effects raised cardiac output significantly. Hydralazine decreased right atrial pressure less than nitroprusside but decreased vascular resistance and raised cardiac output.
Both nitroprusside and hydralazine decreased systemic vascular resistance during tamponade, but only hydralazine raised cardiac output probably because of its lesser effect upon the capacitance vessels. Nitroprusside maintained cardiac output during tamponade despite lowered right atrial pressure but increased cardiac output only after transfusion.
during tamponade of a vasodilator (hydralazine) which has less effect upon the venous capacitance bed.
These studies demonstrate that nitroprusside decreased systemic vascular resistance and maintained but did not increase cardiac output during tamponade when right atrial pressure was permitted to fall. However, when right atrial pressure was maintained by autologous blood transfusion, nitroprusside significantly increased cardiac output during cardiac tamponade. On the other hand, hydralazine increased cardiac output during tamponade without prior blood transfusion.
Methods
The studies were carried out upon three groups of anesthetized mongrel dogs of either sex, weighing 16.8 to 30.6 kg. Group I comprised six dogs which were given sodium nitroprusside intravenously during cardiac tamponade. Group II animals were transfused with autologous blood during tamponade in order to raise the right atrial pressure by 2 to 5 mm Hg. Two weeks before the study, 400 ml blood was harvested aseptically and another 400 ml seven days before the study. The blood was stored in two plastic blood donor bags containing 1.66 g sodium citrate, and 206 mg citric acid in 63 ml solution, and stored under refrigeration at 9°C. Group III consisted of six dogs which received hydralazine intravenously during cardiac tamponade.
The animals were prepared five days before the study with indwelling intrapericardial plastic catheters inserted under pentobarbital sodium anesthesia. On the day of the study the animals were anesthetized with pentobarbital sodium, 30 mg/kg given intravenously, and allowed to breathe spon- Group II animals were given autologous blood harvested 7-14 days previously. The blood was warmed to 37°C and infused intravenously at a rate of 100 ml/min so that right atrial pressure increased rapidly by 3 to 5 mm Hg. The infusion was then continued at the slowest rate that would maintain the elevated RAP constant. After 3-5 min of stabilization two cardiac outputs were performed at three-minute intervals. The other variables were measured as well. Then, as the infusion of blood was continued, usually no faster than 16 ml/min, an infusion of nitroprusside intravenously was begun at the dosage of 16 ,g/kg/min. After this infusion for four minutes and stabilization of pressures, paired cardiac outputs were measured at three-minute intervals; the other variables were measured as well. The nitroprusside infusion was then stopped and, after 7-10 min, the output measurements were repeated. The blood transfusion was stopped and the right atrial and pericardial pressures were returned to the original tamponade levels by bleeding. After stabilization for 3-5 min, paired cardiac outputs and other variables were measured. Cardiac tamponade was relieved by withdrawal of all of the injected fluid. In all experiments fluid was recovered within 5 ml of the amount injected. After five minutes, paired cardiac outputs and the other variables were measured at three minute intervals.
Group III. The six animals in this group were prepared and studied in the same way as those in group I, except that they received as anesthesia morphine, 3 mg/kg subcutaneously and chloralose, 70 mg/kg intravenously. These animals received hydralazine rather than sodium nitroprusside. After duplicate hemodynamic measurements in a control period, paired measurements were made during tamponade. The animals then received 20 mg hydralazine intravenously as a bolus; hemodynamic measurements were repeated four and eight minutes later. The animals then received another bolus injection of 20 mg hydralazine, followed by hemodynamic measurements four and eight minutes later. The four and eight minute measurements were paired and averaged in data analysis. Then the pericardial fluid was removed and paired hemodynamic measurements were repeated.
Total peripheral resistance in arbitrary units was calculated by dividing the difference between mean blood pressure and right atrial pressure, expressed in mm Hg, by cardiac output, expressed in liters per minute. Mean arterial blood pressure was calculated by adding one-third of the arterial pulse pressure to the diastolic blood pressure."
Results
The results are summarized in tables 1, 2 and 3. Table 1 shows the results obtained in the six group I animals with cardiac tamponade given sodium nitroprusside, 16 Ag/kg/min. These animals did not receive blood transfusion. With cardiac tamponade, right atrial pressure (RAP) and intrapericardial pressure (PP) increased and cardiac output fell significantly. Heart rate increased significantly, and stroke volume fell. Mean blood pressure fell, and total peripheral resistance (TPR) rose significantly. The infusion of sodium nitroprusside was followed by significant decrease in RAP, PP, and mean blood pressure. However, cardiac output showed no change, 95.0 ± 11.8 ml/kg/min vs preinfusion value of 99 i 11.5 ml/kg/min; cardiac stroke volume and heart rate also showed no change with nitroprusside, although TPR fell significantly. Following relief of tamponade, cardiac output, blood pressure, and stroke volume returned toward control values. Table 2 shows the results in the eight group II animals with cardiac tamponade given sodium nitroprusside intravenously after right atrial pressure was raised by 3 to 5 mm Hg by transfusion of the animal's previously harvested 2) t vs control (P = NS); * vs control (P <0.05); * vs control (P <0.001).
3) ** vs tamponade (P <0.02); *** vs tamponade (P <0.01); **** vs tamponade (P <0.001).
4) * vs tamponade (P <0.05): ** vs tamponade (P <0.01): *** vs tamponade (P <0.001).
5) ** vs control (P <0.01); *** vs control (P <0.001);°vs control (P = NS).
at a reduced level by increased systemic arterial resistance; cardiac stroke volume is reduced but to some degree maintained by increased systolic ejection. It is probable that nitroprusside infusion, given to decrease left ventricular afterload in the present study, did not increase cardiac stroke volume and cardiac output in the nontransfused animals of group I because the right atrial pressure fell. When cardiac tamponade is induced the compliance of the heart is altered and it is difficult to-determine preload from atrial or ventricular diastolic pressure. However, certain qualitative statements are possible. Since there was no loss of pericardial fluid and since there is no reason to believe that nitroprusside altered pericardial compliance, the pronounced fall in pericardial pressure must mean that there is less diastolic filling of the heart after nitroprusside. Left ventricular diastolic pressure was very close to right atrial pressure during cardiac tamponade. Transfusion of whole blood prior to nitroprusside resulted in a rise in right atrial and in left ventricular diastolic pressure, which undoubtedly was due to increased diastolic size of the heart. Then, when nitroprusside was given, the right atrial and left ventricular diastolic pressures returned to their original values during tamponade. Thus, in all probability cardiac chamber size and preload were maintained and the effect of decreased afterload in increasing cardiac output could be demonstrated. 
